Trulieve Cannabis Board Approves $50M Buyback Program

Dow Jones06-09 20:13

By Adriano Marchese

Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period.

The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation.

Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange.

Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01).

Trulieve can buy back shares until June 16 of next year.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

June 09, 2026 08:13 ET (12:13 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2642467156?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-09 20:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642467156","market":"sg","top_or_hot":-1,"title":"Trulieve Cannabis Board Approves $50M Buyback Program","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n</p>\n<p>\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n</p>\n<p>\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n</p>\n<p>\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n</p>\n<p>\n  Trulieve can buy back shares until June 16 of next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 09, 2026 08:13 ET (12:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trulieve Cannabis Board Approves $50M Buyback Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrulieve Cannabis Board Approves $50M Buyback Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-09 20:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n</p>\n<p>\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n</p>\n<p>\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n</p>\n<p>\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n</p>\n<p>\n  Trulieve can buy back shares until June 16 of next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 09, 2026 08:13 ET (12:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MJ","symbol_name":"Amplify Alternative Harvest ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2642467156","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642467156","pubTimestamp":1781007180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period.The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation.Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange.Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars .Trulieve can buy back shares until June 16 of next year.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MJ":"Amplify Alternative Harvest ETF","YOLO":"AdvisorShares Pure Cannabis ETF","WEED":"Roundhill Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","CNBS":"Amplify Seymour Cannabis ETF","TOKE":"Cambria Cannabis ETF","MSOX":"AdvisorShares MSOX 2X Daily ETF"},"translate_title":"Trulieve Cannabis董事会批准5000万美元回购计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TOKE":1.5,"MJ":1.5,"MSOS":1.5,"YOLO":1.5,"WEED":1.5,"MSOX":1.5,"CNBS":1.5},"content_text":"By Adriano Marchese \n\n\n \n\n\n  Trulieve Cannabis intends to launch a share-repurchase program to buy back up to $50 million over the course of a one-year period. \n\n\n  The medical cannabis company said that its board has authorized the company to repurchase up to around 8.5 million shares for cancellation. \n\n\n  Earlier in the week, Trulieve received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange. Currently its shares are listed on the Canadian Securities Exchange. \n\n\n  Shares on the CSE have been performing well, with the stock rising over 52% since the start of the year to close Monday at 18.15 Canadian dollars ($13.01). \n\n\n  Trulieve can buy back shares until June 16 of next year. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 09, 2026 08:13 ET (12:13 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642467156","isCrawlerRequest":true}